Seeing Is Believing
Healthcare - Sector
ACAD is currently covered by 15 analysts with an average price target of $30.36. This is a potential upside of $6.99 (15.88%) from yesterday's end of day stock price of $26.2.
ACADIA Pharmaceuticals's activity chart (see below) currently has 413 price targets and 334 ratings on display. The stock rating distribution of ACAD is 69.23% BUY, 28.21% HOLD and 2.56% SELL.
Analysts average stock forecasts to be materialized ratio is 57.25% with an average time for these price targets to be met of 251.23 days.
Highest price target for ACAD is $40, Lowest price target is $17, average price target is $30.36.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 30-Jun-2026. First documented stock forecast 06-May-2013.
Currently out of the existing stock ratings of ACAD, 27 are a BUY (69.23%), 11 are a HOLD (28.21%), 1 are a SELL (2.56%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Jun-2026
$30
$4.03 (15.52%)
$29
8 days ago
(30-Jun-2026)
10/13 (76.92%)
$4.7 (18.58%)
275
Buy Since 21-Oct-2025
$35
$9.03 (34.77%)
$32
9 days ago
(29-Jun-2026)
0/4 (0%)
$9.8 (38.89%)
Buy Since 01-Mar-2024
$34
$8.68 (34.28%)
$31
4 months 4 days ago
(04-Mar-2026)
8/15 (53.33%)
$10.61 (45.36%)
113
Buy Since 26-Nov-2019
$35
$9.68 (38.23%)
$34
4 months 12 days ago
(26-Feb-2026)
7/20 (35%)
$10.36 (42.05%)
274
Buy Since 23-Jun-2025
$30
$4.68 (18.48%)
$31
4 months 12 days ago
(26-Feb-2026)
0/6 (0%)
$5.36 (21.75%)
What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?